Funder: Pershing Square Philanthropies
Due Dates (Anticipated): November 2026 (Letter of Intent, projected)
Funding Amounts: Up to $750,000 per award ($250,000/year for 3 years); at least six awards annually
Summary: Supports early-career scientists at U.S. institutions pursuing innovative, high-risk cancer research with funding and access to a collaborative network.
Key Information: No full proposal stage; LOI is the sole application; open to all U.S. institutions as of 2026.